Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferdinando Nicoletti

Showing results (461-470 of 548) with videos related to

Pageof 55
Sort By:
Psychiatry Research|April 26, 2015
Electroconvulsive therapy improves clinical manifestations of treatment-resistant depression without changing serum BDNF levelsChiara Rapinesi, Georgios D Kotzalidis, Martina Curto, et al.
Neuropharmacology|February 26, 2014
Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in miceFrancesco Fazio, Cristina Zappulla, Serena Notartomaso, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 29, 2007
Maternal exposure to low levels of corticosterone during lactation protects the adult offspring against ischemic brain damagePaola Casolini, Maria Rosaria Domenici, Carlo Cinque, et al.
Frontiers in Cellular Neuroscience|September 28, 2018
Dickkopf-3 Causes Neuroprotection by Inducing Vascular Endothelial Growth FactorCarla Letizia Busceti, Luisa Di Menna, Franca Bianchi, et al.
Brain : a Journal of Neurology|September 1, 2023
Inhibiting metabotropic glutamate receptor 5 after stroke restores brain function and connectivityJakob Hakon, Miriana J Quattromani, Carin Sjölund, et al.
Aging|June 4, 2020
Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell linesWilliam H Chappell, Saverio Candido, Stephen L Abrams, et al.
International Journal of Molecular Sciences|November 25, 2020
Immune-Modulating Drug MP1032 with SARS-CoV-2 Antiviral Activity In Vitro: A potential Multi-Target Approach for Prevention and Early Intervention Treatment of COVID-19Sara Schumann, Astrid Kaiser, Ferdinando Nicoletti, et al.
Molecular Brain|November 21, 2013
Pharmacological enhancement of mGlu1 metabotropic glutamate receptors causes a prolonged symptomatic benefit in a mouse model of spinocerebellar ataxia type 1Serena Notartomaso, Cristina Zappulla, Francesca Biagioni, et al.
Cell Cycle (Georgetown, Tex.)|May 4, 2010
The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapyStephen L Abrams, Linda S Steelman, John G Shelton, et al.
Molecules (Basel, Switzerland)|December 22, 2019
In Silico and In Vivo Analysis of IL37 in Multiple Sclerosis Reveals Its Probable Homeostatic Role on the Clinical Activity, Disability, and Treatment with FingolimodEugenio Cavalli, Emanuela Mazzon, Maria Sofia Basile, et al.
Pageof 55

Showing results (461-470 of 548) with videos related to

Sort By:
Pageof 55
Psychiatry Research|April 26, 2015
Electroconvulsive therapy improves clinical manifestations of treatment-resistant depression without changing serum BDNF levelsChiara Rapinesi, Georgios D Kotzalidis, Martina Curto, et al.
Neuropharmacology|February 26, 2014
Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in miceFrancesco Fazio, Cristina Zappulla, Serena Notartomaso, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 29, 2007
Maternal exposure to low levels of corticosterone during lactation protects the adult offspring against ischemic brain damagePaola Casolini, Maria Rosaria Domenici, Carlo Cinque, et al.
Frontiers in Cellular Neuroscience|September 28, 2018
Dickkopf-3 Causes Neuroprotection by Inducing Vascular Endothelial Growth FactorCarla Letizia Busceti, Luisa Di Menna, Franca Bianchi, et al.
Brain : a Journal of Neurology|September 1, 2023
Inhibiting metabotropic glutamate receptor 5 after stroke restores brain function and connectivityJakob Hakon, Miriana J Quattromani, Carin Sjölund, et al.
Aging|June 4, 2020
Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell linesWilliam H Chappell, Saverio Candido, Stephen L Abrams, et al.
International Journal of Molecular Sciences|November 25, 2020
Immune-Modulating Drug MP1032 with SARS-CoV-2 Antiviral Activity In Vitro: A potential Multi-Target Approach for Prevention and Early Intervention Treatment of COVID-19Sara Schumann, Astrid Kaiser, Ferdinando Nicoletti, et al.
Molecular Brain|November 21, 2013
Pharmacological enhancement of mGlu1 metabotropic glutamate receptors causes a prolonged symptomatic benefit in a mouse model of spinocerebellar ataxia type 1Serena Notartomaso, Cristina Zappulla, Francesca Biagioni, et al.
Cell Cycle (Georgetown, Tex.)|May 4, 2010
The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapyStephen L Abrams, Linda S Steelman, John G Shelton, et al.
Molecules (Basel, Switzerland)|December 22, 2019
In Silico and In Vivo Analysis of IL37 in Multiple Sclerosis Reveals Its Probable Homeostatic Role on the Clinical Activity, Disability, and Treatment with FingolimodEugenio Cavalli, Emanuela Mazzon, Maria Sofia Basile, et al.
Pageof 55